Emerging strategies and options: Difference between revisions
From MalariaETC
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
<span style="font-size:90%">Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:</br>(a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, tests may be compiled the identify each with specificity - ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH). This can offer some advantages in detecting dual infection by the two species when compared to using a pan-malarial antibody. | <span style="font-size:90%">'''Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:'''</br></br>(a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, tests may be compiled the identify each with specificity - ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH). This can offer some advantages in detecting dual infection by the two species when compared to using a pan-malarial antibody. | ||
to distinguish between infections by P. falciparum and P. vivax. | to distinguish between infections by P. falciparum and P. vivax. | ||
Alternatively, tests can be multiplexed to select for Pf-pLDH and HRP2, which yields highly sensitive indications for falciparum malaria. [16] Multiplexed RDTs have also proven to be efficacious in discriminating between distinct diseases with non-specific symptomatic presentations. | Alternatively, tests can be multiplexed to select for Pf-pLDH and HRP2, which yields highly sensitive indications for falciparum malaria. [16] Multiplexed RDTs have also proven to be efficacious in discriminating between distinct diseases with non-specific symptomatic presentations. | ||
Revision as of 14:37, 13 September 2024
Navigation
Go Back
| Emerging Strategies
|